ITC tadalafil investigation
International Trade Commission launches investigation into a complaint filed by Lilly ICOS seeking an order barring importation or marketing in the U.S. of tadalafil that infringes its U.S. patent 5,859,006 for Cialis, the commission says May 16. The complaint names 10 Internet marketers of the infringing product. The '006 patent expires in January 2016, according to the Orange Book. Lilly notes it has not been able to discover any producers of unapproved generic tadalafil in the U.S. The ITC expects to hold a hearing on the investigation in early fall...
You may also be interested in...
CRLs FDA submits in response to ANDAs increased most years since FY 2015, though FY 2020 total likely will be lower than two previous years. A 2019 CRL interrupted GSK's plans to market first mouth spray nicotine replacement therapy in US.
The US FDA appears to have concerns about the device used to administer the vaccine.
The US Medicare agency has released a quick-start guide for laboratory certification.